Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Harrow Health, Inc. 8.625% Senior Notes due 2026

HROWL•NASDAQ
Healthcare
Medical - Pharmaceuticals
$25.61
$0.05(0.19%)
U.S. Market opens in 10h 34m

Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) Stock Overview

Explore Harrow Health, Inc. 8.625% Senior Notes due 2026’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.4B
P/E Ratio-383.59
EPS (TTM)N/A
ROE-0.09%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$25.03

HROWL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 77.47, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $25.03.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -383.59 and a market capitalization of 1.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.20%
3-Month Change
0.83%
6-Month Change
1.39%
Year-to-Date (YTD) Change
1.23%
1-Year Change
1.43%
3-Year Change
8.52%
5-Year Change
2.89%
All-Time (Max) Change
2.89%

Contact Information

http://www.harrowinc.com
NaN
NaN, Nashville, DE, NaN

Company Facts

2,170 Employees
IPO DateMay 7, 2021
CountryUS

Frequently Asked Questions